Ocean Biomedical, Inc. SEC filings OCEA

Ocean Biomedical, Inc. has 255 filings in SEC EDGAR's recent list, going back to Jul 19, 2021. Its latest annual report, Form 10-K, was filed on Apr 8, 2025 for the period ended Dec 31, 2024. The latest quarterly report (Form 10-Q) was filed on May 15, 2025, covering the quarter ended Mar 31, 2025. The most recent current report (Form 8-K) was filed on Aug 5, 2025 (listing notice, officer or director change, other events). The company's fiscal year ends on December 31.

Form Description Filed Period
DEFA14A Additional proxy material Mar 10, 2025 —
DEF 14A Proxy statement Feb 26, 2025 Feb 26, 2025
PRE 14A Preliminary proxy statement Feb 14, 2025 Feb 14, 2025
DEF 14A Proxy statement Aug 4, 2023 Aug 4, 2023
PRE 14A Preliminary proxy statement Jul 24, 2023 Jul 24, 2023
DEF 14A Proxy statement Jan 12, 2023 Jan 12, 2023
PRE 14A Preliminary proxy statement Nov 23, 2022 Nov 23, 2022
PREM14A Filing Nov 22, 2022 Nov 22, 2022
PREM14A Filing Sep 16, 2022 Sep 16, 2022

Showing 9 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
OCEA (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
, Emerging growth company
SEC CIK
1869974
Former names
Ocean Biomedical, Inc./DE (until Feb 15, 2023); Aesther Healthcare Acquisition Corp. (until Feb 14, 2023)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.